Collagen and elastin turnover increase at COPD exacerbation irrespectively its etiology

E. Papakonstantinou (Basel, Switzerland), J. Sand (Herlev, Denmark), L. Grize (Basel, Switzerland), H. Hirsch (Basel, Switzerland), M. Tamm (Basel, Switzerland), M. Karsdal (Herlev, Denmark), D. Stolz (Basel, Switzerland)

Source: Virtual Congress 2020 – New biomarkers for management of obstructive diseases
Session: New biomarkers for management of obstructive diseases
Session type: Oral Presentation
Number: 4720
Disease area: Airway diseases, Respiratory infections

Congress or journal article abstractWebcastSlide presentationE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
E. Papakonstantinou (Basel, Switzerland), J. Sand (Herlev, Denmark), L. Grize (Basel, Switzerland), H. Hirsch (Basel, Switzerland), M. Tamm (Basel, Switzerland), M. Karsdal (Herlev, Denmark), D. Stolz (Basel, Switzerland). Collagen and elastin turnover increase at COPD exacerbation irrespectively its etiology. 4720

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Collagen degradation profile in serum of patients with COPD or IPF
Source: Annual Congress 2012 - Monitoring of airway diseases: far from the airways
Year: 2012



Age-dependent elastin degradation is enhanced in chronic obstructive pulmonary disease
Source: Eur Respir J 2016; 48: 1215-1218
Year: 2016


Age-dependent systemic elastin degradation is enhanced in chronic obstructive pulmonary disease
Source: International Congress 2016 – New signalling pathways in COPD
Year: 2016


Elevated type I collagen degradation predicts persistent asthma in children
Source: Virtual Congress 2020 – Novel mechanisms and management of paediatric asthma
Year: 2020


Serum levels of a MMP-12 generated type IV collagen fragment is elevated in COPD and IPF patients
Source: Annual Congress 2013 –Systemic and airway biomarkers in respiratory diseases
Year: 2013


Characterization of elastin degradation biomarkers in chronic obstructive pulmonary disease (COPD)
Source: Annual Congress 2008 - Pulmonary vascular disease and other pulmonary conditions: miscellaneous
Year: 2008


Parameters of sIgE and sIgG4-autoAbs to lung elastin, collagen type III and myosin in bronchial asthma in association with chronic infection.
Source: International Congress 2019 – Understanding the mechanisms underlying airway diseases
Year: 2019

Altered expression of glycosaminoglycans in the BAL of COPD patients with acute exacerbation
Source: Annual Congress 2013 –Translational studies in chronic lung diseases: from bedside to bench
Year: 2013

Accelerated age-dependent elastin degradation in bronchiectasis
Source: Virtual Congress 2021 – Pathogenic progress in airway diseases
Year: 2021


Lung fibroblasts from COPD patients presented a reduced response to TGF-β1 for proliferation and elastin synthesis
Source: Annual Congress 2011 - Molecular: pathology of infectious and inflammatory lung disease
Year: 2011

Reduced myofibrillar protein breakdown in stable patients with chronic obstructive pulmonary disease (COPD)
Source: Eur Respir J 2004; 24: Suppl. 48, 459s
Year: 2004

Increased laminin deposition and expression of TGF-beta in bronchial biopsies of children with chronic obstructive respiratory diseases
Source: Annual Congress 2013 –Paediatric bronchology
Year: 2013


Elastin expression in very severe human COPD
Source: Eur Respir J 2009; 33: 324-331
Year: 2009



Serologically assessed elastin degradation is related to force vital capacity in patients with IPF
Source: Annual Congress 2013 –Translational studies in chronic lung diseases: from bedside to bench
Year: 2013


Cellular composition of bronchial brush-biopsies in dependence on smoking and etiology of COPD exacerbation
Source: Eur Respir J 2007; 30: Suppl. 51, 403s
Year: 2007

Decreased hyaluronan in airway smooth muscle cells from patients with asthma and COPD
Source: Eur Respir J 2009; 34: 616
Year: 2009



Remodelling in the bronchi of patients with COPD: defective ECM deposition and repair by pulmonary fibroblasts
Source: Annual Congress 2013 –Immunopathology of COPD: contribution of advancements of new therapeutic agents
Year: 2013


Extracellular matrix composition in COPD
Source: Eur Respir J 2012; 40: 1362-1373
Year: 2012



Does inflammation decrease after recovery from severe exacerbation of COPD?
Source: Eur Respir J 2005; 26: Suppl. 49, 53s
Year: 2005

Clinical features and outcome of patients with acute exacerbation of interstitial pneumonia associated with collagen vascular disease
Source: Annual Congress 2010 - Clinical aspects in pulmonary fibrosis
Year: 2010